Diabetic Retinopathy Market (By Type: Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy; By Age Group: 40-49, 65-74, 50-64; By Management: Vitrectomy, Anti-VEGF, Intracular Steroid Injection, Laser Surgery; By Distribution Channel: Hospitals and Pharmacies, Ambulatory Surgical Centers (ASCs), Eye Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Diabetic Retinopathy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Diabetic Retinopathy Market, by Type, 2024-2033
8.1.1. Proliferative Diabetic Retinopathy
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Non-Proliferative Diabetic Retinopathy
8.1.2.1. Market Revenue and Forecast (2021-2033)
9.1. Diabetic Retinopathy Market, by Age Group, 2024-2033
9.1.1. 40-49
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. 65-74
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. 50-64
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. Diabetic Retinopathy Market, by Management, 2024-2033
10.1.1. Vitrectomy
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Anti-VEGF
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Intracular Steroid Injection
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Laser Surgery
10.1.4.1. Market Revenue and Forecast (2021-2033)
11.1. Diabetic Retinopathy Market, by Distribution Channel, 2024-2033
11.1.1. Hospitals and Pharmacies
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Ambulatory Surgical Centers (ASCs)
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Eye Clinics
11.1.3.1. Market Revenue and Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2021-2033)
12.1.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.1.3. Market Revenue and Forecast, by Management (2021-2033)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Management (2021-2033)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Management (2021-2033)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.2.3. Market Revenue and Forecast, by Management (2021-2033)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Management (2021-2033)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Management (2021-2033)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Management (2021-2033)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Management (2021-2033)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.3.3. Market Revenue and Forecast, by Management (2021-2033)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Management (2021-2033)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Management (2021-2033)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Management (2021-2033)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Management (2021-2033)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.4.3. Market Revenue and Forecast, by Management (2021-2033)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Management (2021-2033)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Management (2021-2033)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Management (2021-2033)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Management (2021-2033)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.5.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.5.3. Market Revenue and Forecast, by Management (2021-2033)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Management (2021-2033)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Age Group (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Management (2021-2033)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)
13.1. Bayer AG
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. ABBVIE INC.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Novartis AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Oxurion NV
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sirnaomics
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Alimera Sciences
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Ampio Pharmaceuticals Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. BCNPeptides
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Kowa Company Ltd.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Genentech, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample